Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Health
Fabian Werner

Uruguay confirms presence of Brazilian COVID-19 variant

FILE PHOTO: Health workers register prisoners before they receive the Sinovac coronavirus disease (COVID-19) vaccine during a campaign to vaccinate prisoners at the Unit four of the Santiago Vazquez prison, in Montevideo, Uruguay March 19, 2021. REUTERS/Ana Ferreira Cirigliano/File Photo

Uruguay confirmed on Monday that it had detected the presence of two coronavirus variants that originated in neighbouring Brazil as the tiny South American nation faces a spike in cases and deaths.

Scientists examined 175 COVID-19 samples taken from around the country and found the Brazilian P1 strain in 24 of them and the P2 variant in four.

Gregorio Iraola, a scientist with Uruguay's Inter-Institutional Working Group (GTI) conducting genome sequencing of COVID-19 cases, said the P2 variant was now being transmitted within the wider community rather than brought in from overseas, making tackling the outbreak "more complicated."

Uruguayan President Luis Lacalle Pou has called a cabinet meeting on Tuesday to address the issue.

Uruguay, which has a population 3.5 million, has in recent weeks seen a spike in new cases, deaths and demand for hospital intensive care beds, with occupancy rates for the latter reaching 64%, the Uruguayan Society of Intensive Care Medicine said in a report. COVID-19 patients accounted for 22% of those beds.

It warned that if urgent measures are not taken to reduce infections, hospital bed occupancy could soar to 85% by April 4.

Both the P1 and P2 COVID-19 strains have been identified as spreading rapidly in Brazil, which has the world's highest daily caseload at present.

Early studies suggest they can overcome some antibodies, increase a person's chances of reinfection and diminish the efficacy of vaccines.

Oxford University study published last week that suggested antibodies developed through both natural illness and vaccines can still neutralise such variants, albeit at lower levels.

(Reporting by Fabian Werner, writing by Aislinn Laing; Editing by Sam Holmes)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.